Cancer

When eating is difficult: How to get good nutrition during cancer treatment

Providence Cancer Institute dietitian answers questions and offers helpful tips.

• Facebook

New study evaluates a medication for NSCLC with the KRAS G12C mutation

Many people with advanced NSCLC still need better treatment options. This study is evaluating an investigational medication that may help them live longer.

• Facebook

Restoring intimacy after cancer: One woman’s story

A sexual health professional at Providence helped Ellen regain her sense of self after treatment for endometrial cancer.

• Facebook

Dark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance

Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.

• Facebook

A new liver cancer trial explores a “two-in-one" treatment approach

Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.

• Facebook

Providence Cancer Institute secures three significant grants

Prestigious grants will help researchers pursue important cancer studies.

• Facebook

Pluvicto therapy provides innovative cancer treatment closer to home

• Facebook

Q&A: Meet one of the investigational drug pharmacists at Providence

An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.

• Facebook

New T-cell therapy for KRAS G12D cancers

An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.

• Facebook

Guiding Patients from Cancer Diagnosis through Survivorship

At Providence St. Joseph Hospital Eureka, cancer care extends far beyond diagnosis and treatment.

• Facebook

Precision treatment for prostate cancer with MRI-guided radiation therapy

Advanced imaging technology allows clinicians to deliver targeted prostate cancer treatment while helping protect healthy tissue and reduce side effects. Dr. Amar Srivastava describes what's new.

• Facebook

When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.

• Facebook

One Day at a Time: Samantha's Journey Through Metastatic Melanoma

After being diagnosed with mmelanoma while in nursing school and facing a recurrence more than a decade later, Samantha Ybaro continues to move forward with resilience, gratitude and a message of hope

• Facebook

Hope comes in a clinical trial: Brad’s remarkable story

When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.

• Facebook

Back on the Dance Floor: How Targeted Therapy Helped Gene Keep Moving

After his prostate cancer progressed despite treatment, Gene found new possibilities through Pluvicto, an innovative radioligand therapy.

• Facebook

Colonoscopies finding a high rate of early onset colorectal cancer, Providence study finds

• Facebook

Providence researchers head to Chicago for leading cancer conference

Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

• Facebook

Adoptive cell therapy: Phase III study open for people with advanced melanoma

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

• Facebook

It started with one bandage, and a patient’s smile

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

• Facebook